Sign in

CIK 0001720580

  • Non-accelerated filer
  • Smaller reporting company

Adicet Bio, Inc.

Sign in to watch
Ticker
ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 26
Incorporated
DE
Entity type
Operating
EIN
813305277
Phone
+1 617-482-2333
Business address
131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
Former names
resTORbio, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale President and CEO sold 16,466 shares at $12.01 ($197,676)
  4. 4 Open-market sale President and CEO sold 16,466 shares at $13.04 ($214,700)
  5. 4 Open-market sale President and CEO sold 16,466 shares at an average $12.85 ($211,640)
  6. 4/A Open-market sale President and CEO sold 16,466 shares at an average $15.34 ($252,558)
  7. 4/A Shares withheld for taxes President and CEO gave up 8,649 shares (to pay taxes)
  8. 4 Open-market sale President and CEO sold 16,466 shares at an average $15.34 ($252,558)
  9. 4 Grant or award Chief Innovation Officer acquired 16,888 shares (grant or award)
  10. 4/A Derivatives Options or other derivatives
  11. 3/A Insider 3/A
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award Director acquired 524,349 shares (grant or award)
  15. 4 Grant or award Director acquired 524,349 shares (grant or award)
  16. 4 Grant or award Director acquired 524,349 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 15 · 288 filings